Monica Gelzo

Ceinge Biotecnologie Avanzate (Italy)

Papers

1

Total Citations

47

H-Index

1

About

Monica Gelzo is a researcher whose work sits at the intersection of clinical biochemistry and oxidative stress, with a particular focus on urological oncology. Her key research areas include the identification and validation of urinary biomarkers for prostate cancer, specifically those related to oxidative damage. In her most cited work, Gelzo investigated the utility of 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-iso-prostaglandin F2α (8-IsoF2α) as putative biomarkers for assessing oxidative stress following robot-assisted radical prostatectomy (RARP). This study, which has garnered 47 citations, provides crucial insights into the pathophysiological mechanisms of prostate cancer and contributes to the refinement of diagnostic panels. By demonstrating that these oxidative stress markers are measurable and clinically relevant in a surgical context, Gelzo’s research advances the understanding of how oxidative damage can be monitored in cancer patients. Her work is notable for bridging the gap between basic oxidative stress biology and practical, post-surgical clinical assessment, offering potential tools for improving patient management and outcome prediction in prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
47 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Ceinge Biotecnologie Avanzate (Italy)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago